Double maintains 4 strategies that include ELAN - Elanco Animal Health, Inc.
Current Value
$14.861 Year Return
Current Value
$14.861 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| DIS | 59.14% | $219.00B | +25.52% | 1.19% |
| KE | 58.75% | $491.27M | -4.09% | 0.00% |
| SHOO | 58.75% | $1.86B | -40.03% | 3.28% |
| LIVN | 56.78% | $2.54B | -7.29% | 0.00% |
| CRL | 55.21% | $7.78B | -21.53% | 0.00% |
| VOYA | 54.40% | $7.00B | +3.22% | 2.47% |
| A | 53.77% | $34.37B | -3.52% | 0.81% |
| GEN | 53.61% | $18.57B | +24.08% | 1.67% |
| ACRE | 53.37% | $260.73M | -30.60% | 16.88% |
| ROK | 52.34% | $38.11B | +29.44% | 1.51% |
| MKSI | 52.34% | $7.01B | -22.60% | 0.84% |
| MTD | 52.20% | $25.08B | -7.76% | 0.00% |
| IPGP | 52.20% | $3.11B | -13.56% | 0.00% |
| DEI | 51.55% | $2.62B | +16.80% | 4.84% |
| WWW | 51.55% | $1.58B | +56.90% | 2.06% |
| ZBRA | 51.24% | $16.43B | +2.48% | 0.00% |
| LAMR | 51.11% | $12.65B | +4.46% | 4.67% |
| BN | 51.02% | $103.50B | +46.08% | 0.54% |
| TECH | 50.99% | $8.26B | -26.10% | 0.61% |
| AVNT | 50.61% | $3.09B | -18.79% | 3.14% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TIPX | -0.03% | $1.73B | 0.15% |
| FXB | 0.42% | $91.78M | 0.4% |
| CTA | 0.50% | $1.06B | 0.76% |
| GDX | 0.59% | $15.71B | 0.51% |
| CGSM | 0.60% | $716.04M | 0.25% |
| CANE | -0.61% | $11.26M | 0.29% |
| UTEN | -0.66% | $210.22M | 0.15% |
| BNDX | 0.78% | $67.61B | 0.07% |
| GOAU | 0.91% | $126.18M | 0.6% |
| MLN | 0.99% | $514.61M | 0.24% |
| IBTP | 1.11% | $142.32M | 0.07% |
| IEF | -1.16% | $34.44B | 0.15% |
| BSMR | -1.18% | $258.34M | 0.18% |
| GSY | -1.19% | $2.89B | 0.22% |
| DFNM | -1.22% | $1.58B | 0.17% |
| SMB | -1.42% | $274.58M | 0.07% |
| STXT | -1.57% | $128.76M | 0.49% |
| BAB | 1.67% | $928.83M | 0.28% |
| CORN | 1.67% | $45.73M | 0.2% |
| NEAR | -1.75% | $3.32B | 0.25% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| HAIN | -17.08% | $146.21M | -76.52% | 0.00% |
| CBOE | -16.18% | $24.35B | +37.95% | 1.09% |
| BGS | -13.83% | $336.75M | -45.05% | 17.99% |
| AGL | -12.88% | $989.35M | -58.43% | 0.00% |
| KR | -11.41% | $46.11B | +34.48% | 1.84% |
| YORW | -10.26% | $460.52M | -13.43% | 2.72% |
| MYGN | -10.24% | $511.58M | -78.01% | 0.00% |
| LNTH | -9.91% | $5.70B | +6.06% | 0.00% |
| MKTX | -9.89% | $8.13B | +6.08% | 1.38% |
| CME | -9.27% | $99.33B | +45.14% | 1.75% |
| ED | -8.84% | $35.78B | +11.77% | 3.38% |
| DUK | -8.70% | $90.40B | +15.23% | 3.60% |
| ALHC | -7.46% | $2.71B | +75.99% | 0.00% |
| GFI | -7.33% | $20.91B | +50.71% | 2.38% |
| DFDV | -7.12% | $298.06M | +2,070.86% | 0.00% |
| TEF | -7.10% | $29.46B | +22.82% | 6.25% |
| TU | -6.87% | $25.24B | +7.19% | 6.97% |
| PSQH | -6.31% | $101.55M | -38.06% | 0.00% |
| AWK | -6.09% | $27.50B | +7.88% | 2.23% |
| UNH | -5.92% | $279.13B | -37.47% | 2.81% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -46.38% | $185.99M | 0.85% |
| TAIL | -45.36% | $95.09M | 0.59% |
| BTAL | -36.64% | $312.42M | 1.43% |
| IVOL | -30.84% | $342.02M | 1.02% |
| XONE | -22.73% | $627.68M | 0.03% |
| ULST | -20.26% | $595.49M | 0.2% |
| FXY | -19.14% | $812.67M | 0.4% |
| XHLF | -18.35% | $1.73B | 0.03% |
| BILS | -17.68% | $3.80B | 0.1356% |
| SPTS | -17.28% | $5.77B | 0.03% |
| TBLL | -16.69% | $2.12B | 0.08% |
| BIL | -16.23% | $41.97B | 0.1356% |
| UTWO | -15.75% | $376.38M | 0.15% |
| STPZ | -15.62% | $443.02M | 0.2% |
| VGSH | -14.83% | $22.64B | 0.03% |
| SCHO | -14.73% | $11.00B | 0.03% |
| GBIL | -14.28% | $6.35B | 0.12% |
| FXE | -13.72% | $585.58M | 0.4% |
| FTSD | -13.14% | $233.04M | 0.25% |
| XBIL | -12.91% | $784.40M | 0.15% |
Yahoo
Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Department of Agriculture (USDA) has approved TruCan Ultra CIV H3N2/H3N8, a canine influenza vaccine designed to provide broad respiratory disease protection. The approval of TruCan Ultra CIV completes Elanco's Tru Portfolio of comfortable and convenient combination vaccines made with PureFil™ Technology, an exclusive process for creating highly purified vaccines designed to reduce adverse reactions and deliver better experi
Finnhub
Elanco Animal Health said onWednesday the U.S. Department of Agriculture has approvedits canine flu vaccine, which offers dogs protection againstserious respiratory disease. The...
Finnhub
Elanco Animal Health Incorporated announced the U.S. Department of Agriculture has approved TruCan Ultra CIV H3N2/H3N8, a canine influenza vaccine designed to provide broad respiratory disease...
Finnhub
Elanco Animal Health Inc: Elanco receives USDA approval for Trucan™ Ultra Civ H3N2/H3N8 bringing to market a high standard of respiratory protection Elanco Animal Health Inc - Trucan Ultra...
Yahoo
Elanco Animal Health (ELAN) has entered into an exclusive global licensing agreement with Neurizon T
Yahoo
Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased to announce it has executed an exclusive global license agreement with Elanco Animal Health Incorporated (Elanco; NYSE: ELAN) and affiliates for Monepantel, the active pharmaceutical ingredient in NUZ-001, Neurizon's lead investigational therapy in development for Amyotrophic Lateral Sclerosis (ALS
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| KROS | -0.08% | $564.96M | -67.45% | 0.00% |
| QNRX | 0.09% | $5.13M | -58.29% | 0.00% |
| SAND | 0.10% | $2.86B | +74.73% | 0.59% |
| PPC | -0.23% | $10.85B | +36.15% | 0.00% |
| MUSA | 0.24% | $8.17B | -9.17% | 0.47% |
| IMXI | 0.26% | $313.26M | -47.43% | 0.00% |
| CLLS | 0.27% | $116.07M | -15.93% | 0.00% |
| IMDX | 0.33% | $83.22M | -2.68% | 0.00% |
| TIGO | -0.37% | $6.37B | +49.96% | 6.75% |
| RGLD | -0.38% | $10.55B | +21.98% | 1.10% |
| BCE | -0.46% | $22.04B | -24.19% | 10.28% |
| CYD | 0.53% | $913.95M | +160.81% | 3.69% |
| CPSH | 0.65% | $38.93M | +59.05% | 0.00% |
| AGI | 0.72% | $10.98B | +56.29% | 0.38% |
| BOW | 0.73% | $1.14B | +34.24% | 0.00% |
| STG | 0.80% | $31.09M | -22.74% | 0.00% |
| ASPS | 0.83% | $129.76M | +30.25% | 0.00% |
| CCRN | 0.91% | $418.97M | -3.84% | 0.00% |
| EZPW | -0.93% | $751.49M | +40.68% | 0.00% |
| SPTN | -0.97% | $898.36M | +47.53% | 3.30% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| MOAT | 56.83% | $12.97B | 0.47% |
| FXD | 56.31% | $334.62M | 0.61% |
| QDF | 55.27% | $1.89B | 0.37% |
| JVAL | 55.24% | $530.83M | 0.12% |
| RSPD | 55.11% | $203.89M | 0.4% |
| QQQJ | 54.97% | $630.82M | 0.15% |
| RSP | 54.75% | $74.37B | 0.2% |
| DUHP | 54.67% | $8.84B | 0.21% |
| FLQM | 54.26% | $1.71B | 0.3% |
| SMOT | 54.14% | $402.09M | 0.49% |
| JQUA | 54.13% | $6.48B | 0.12% |
| PJUN | 54.06% | $753.17M | 0.79% |
| SIZE | 53.93% | $345.71M | 0.15% |
| JHMM | 53.81% | $4.21B | 0.42% |
| QQQE | 53.63% | $1.24B | 0.35% |
| DFAC | 53.62% | $35.51B | 0.17% |
| BUFZ | 53.62% | $524.38M | 0.95% |
| IUS | 53.56% | $646.00M | 0.19% |
| KRMA | 53.53% | $656.49M | 0.43% |
| IWR | 53.50% | $43.01B | 0.19% |
